Biopharmaceutical fermentation systems market seen reaching $41.42 billion by 2030

17 hours ago
Biopharmaceutical fermentation systems market seen reaching $41.42 billion by 2030
By AI, Created 16:30 UTC, Nov 20, 2026, AGP -

The biopharmaceutical fermentation systems market is projected to climb from $26.6 billion in 2025 to $41.42 billion by 2030, driven by biologics demand, automation and expanding biomanufacturing. North America held the largest regional share in 2025, while the report points to growth opportunities across Asia-Pacific, Europe and emerging markets.

Why it matters: - Biopharmaceutical fermentation systems are central to making biologic medicines, including proteins, antibodies and vaccines. - The market’s projected growth signals rising demand for the manufacturing infrastructure behind complex therapies. - The expansion also reflects broader investment in biomanufacturing capacity, automation and personalized medicine.

What happened: - The Business Research Company released its Biopharmaceutical Fermentation Systems Global Market Report 2026. - The report estimates the market at $26.6 billion in 2025. - The market is projected to reach $28.97 billion in 2026. - The report forecasts the market will reach $41.42 billion by 2030. - The report cites a 2025-2026 CAGR of 8.9% and a 2026-2030 CAGR of 9.4%.

The details: - A biopharmaceutical fermentation system is used to grow microorganisms or cells under controlled conditions for biopharmaceutical production. - Bioreactors or fermenters regulate temperature, pH, oxygen levels and nutrient supply to support cell growth and product synthesis. - Growth drivers include early adoption of bioreactors, stronger demand for monoclonal antibodies, more R&D in biopharmaceuticals, and growth in contract manufacturing and research organizations. - The report also points to technology upgrades in fermentation equipment as a growth factor. - The expanding biologics pipeline is another key driver. - Biologics include vaccines, blood products, gene therapies, tissues and recombinant therapeutic proteins. - In 2023, the FDA approved 55 new drugs, including 29 new chemical entities and 25 new biological entities, up from 37 approvals in 2022. - The report says those approvals highlight rising demand for fermentation systems. - Emerging trends include advanced bioreactor design, single-use and disposable systems, high-throughput fermentation, real-time monitoring and tighter upstream-downstream integration. - North America held the largest market share in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests biomanufacturing is moving from a capacity buildout phase to a more technology-driven phase. - Single-use systems, analytics and automation point to a market that is trying to improve speed, flexibility and process control. - The regional breakdown shows that demand is no longer limited to the U.S. and Europe, with emerging markets becoming more important. - The report’s expanded tools, including TAM analysis and company scoring matrices, indicate stronger interest in market intelligence for investment and competitive positioning.

What's next: - The report expects growth to continue as biologics output rises and more manufacturers adopt automated fermentation systems. - Market momentum will likely depend on regulatory support, capacity expansion and adoption of newer bioreactor technologies. - The full report and free sample are available here and here.

The bottom line: - Biopharmaceutical fermentation systems are becoming a bigger and more strategic part of drug manufacturing as biologics demand rises worldwide.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.